Treatment outcomes for acquired aplastic anemia in children
Part of Blood & lymphatic clinical trials.
This study looks at how well treatments work for children with acquired aplastic anemia, a condition where the bone marrow stops making enough blood cells. It aims to help doctors understand which treatments are most effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 18 years old.
- Your child must have been diagnosed with acquired aplastic anemia, confirmed by a bone marrow biopsy.
- The diagnosis must have been made or treated at Assiut University Children's Hospital between August 2023 and August 2026.
- Your child must not have inherited bone marrow failure syndromes (like Fanconi anemia) or other bone marrow diseases.
- Your child must not have had chemotherapy or radiation therapy in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at children with acquired aplastic anemia in the Assiut area in Egypt. It aims to understand more about the disease and how it affects children. If your child fits the criteria, joining could help improve care for others with this condition.
This study tests whether adding umbilical cord blood to a stem cell transplant from a half-matched donor can improve outcomes for people with severe aplastic anemia or related bone marrow failure diseases.
This trial tests whether an early bone marrow transplant from a half-matched family member or an unrelated donor can help people with severe aplastic anemia. It aims to restore the body's ability to make healthy blood cells.
This Phase 2 study looks at doing a bone marrow transplant from a carefully matched donor right away in children with idiopathic aplastic anemia. It aims to improve chances of recovery using a donor that closely matches the patient when a sibling or family donor is not available.
This trial tests two different sources of donor cells for a transplant in patients with severe aplastic anemia (a condition where the bone marrow stops making enough blood cells). The study compares using cells from blood alone versus cells from both bone marrow and blood, to see which approach works better.
This trial tests a new type of transplant using donated cord blood for adults with aplastic anemia that has not improved with standard treatments. It aims to see if the transplant is safe and effective.
Hear when a new Aplastic Anaemia (AA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.